Treatment of Anxiety Disorders in School Maladaptation with Adaptol

A total of 336 children aged 7‐14 years with signs of school maladaptation (SMA) were studied. Anxiety disorders were detected in 167 (49.7%) of the cohort: generalized anxiety disorder in 87 (25.9%), phobic disorders in 40 (11.3%), separation-associated anxiety disorder in 14 (4.2%), and social anxiety disorder in 26 (7.7%). These rates were significantly different from a reference group (children without SMA). Children with generalized anxiety disorder (n = 32) were treated with Adaptol at a dose of 1000 mg/day for 30 days. Adaptol was found to be highly effective in terms of both clinical and psychological investigations, had good tolerance, and produced virtually no side effects.